norfloxacin has been researched along with Infections, Salmonella in 24 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the clinical and microbiologic efficacy and safety of norfloxacin for acute diarrhea." | 9.07 | Empiric treatment of acute diarrheal disease with norfloxacin. A randomized, placebo-controlled study. Swedish Study Group. ( Ekwall, E; Englund, G; Hogevik, H; Jertborn, M; Lagergren, L; Lundholm, R; Norlin, K; Söderquist, B; Strömberg, A; Wiström, J, 1992) |
| "To evaluate the clinical and microbiologic efficacy and safety of norfloxacin for acute diarrhea." | 5.07 | Empiric treatment of acute diarrheal disease with norfloxacin. A randomized, placebo-controlled study. Swedish Study Group. ( Ekwall, E; Englund, G; Hogevik, H; Jertborn, M; Lagergren, L; Lundholm, R; Norlin, K; Söderquist, B; Strömberg, A; Wiström, J, 1992) |
| " Norfloxacin 400 mg per day had been introduced three months earlier as secondary prophylaxis for spontaneous bacterial peritonitis." | 3.72 | [Spontaneous infection of ascitic fluid due to Salmonella typhimurium in a cirrhotic patient undergoing selective intestinal decontamination with norfloxacin]. ( Colin, R; Di Fiore, F; Goria, O; Hervé, S; Lecleire, S; Lerebours, E; Savoye, G, 2003) |
| "Coincidence of salmonellosis and ulcerative colitis is a rare clinical problem." | 1.32 | Salmonellosis and ulcerative colitis. A causal relationship or just a coincidence. ( Erkus, M; Ertem, GT; Karaoglu, AO; Yukselen, V, 2004) |
| "Oral norfloxacin has promising properties for solving this problem, though it has potential toxicity to infants." | 1.28 | Failure of norfloxacin to eradicate intestinal colonization of non-typhoidal salmonella in infants. ( Phuapradit, P; Sirinavin, S, 1989) |
| " Oral administration and twice daily dosing are significant advantages." | 1.27 | Norfloxacin in the eradication of enteric infections in AIDS patients. ( Appleman, MD; Causey, DM; Corrado, ML; Heseltine, PN; Leedom, JM, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (25.00) | 18.7374 |
| 1990's | 12 (50.00) | 18.2507 |
| 2000's | 5 (20.83) | 29.6817 |
| 2010's | 1 (4.17) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Utrarachkij, F | 1 |
| Nakajima, C | 1 |
| Changkwanyeun, R | 1 |
| Siripanichgon, K | 1 |
| Kongsoi, S | 1 |
| Pornruangwong, S | 1 |
| Changkaew, K | 1 |
| Tsunoda, R | 1 |
| Tamura, Y | 1 |
| Suthienkul, O | 1 |
| Suzuki, Y | 1 |
| Lecleire, S | 1 |
| Di Fiore, F | 1 |
| Hervé, S | 1 |
| Goria, O | 1 |
| Savoye, G | 1 |
| Colin, R | 1 |
| Lerebours, E | 1 |
| Sirinavin, S | 2 |
| Thavornnunth, J | 1 |
| Sakchainanont, B | 1 |
| Bangtrakulnonth, A | 1 |
| Chongthawonsatid, S | 1 |
| Junumporn, S | 1 |
| Karaoglu, AO | 1 |
| Yukselen, V | 1 |
| Ertem, GT | 1 |
| Erkus, M | 1 |
| Nagler, JM | 1 |
| Van de Vijvere, M | 1 |
| Levy, J | 1 |
| Mertens, AH | 1 |
| Bassily, S | 1 |
| Hyams, KC | 1 |
| el-Masry, NA | 1 |
| Farid, Z | 1 |
| Cross, E | 1 |
| Bourgeois, AL | 1 |
| Ayad, E | 1 |
| Hibbs, RG | 1 |
| Pitkäjärvi, T | 1 |
| Kujanne, E | 1 |
| Sillantaka, I | 1 |
| Lumio, J | 1 |
| Shetty, M | 1 |
| Shivananda, PG | 1 |
| Moolasart, P | 1 |
| Eampokalap, B | 1 |
| Ratanasrithong, M | 1 |
| Ghadage, DP | 2 |
| Bal, AM | 2 |
| Miragliotta, G | 1 |
| Wiström, J | 1 |
| Jertborn, M | 1 |
| Ekwall, E | 1 |
| Norlin, K | 1 |
| Söderquist, B | 1 |
| Strömberg, A | 1 |
| Lundholm, R | 1 |
| Hogevik, H | 1 |
| Lagergren, L | 1 |
| Englund, G | 1 |
| Khoshoo, V | 1 |
| Raj, P | 1 |
| Srivastava, R | 1 |
| Bhan, MK | 1 |
| Fujii, R | 1 |
| Meguro, H | 1 |
| Arimasu, O | 1 |
| Ushijima, K | 1 |
| Abe, T | 1 |
| Nakazawa, S | 1 |
| Sato, H | 1 |
| Narita, A | 1 |
| Niino, K | 1 |
| Ichihashi, H | 1 |
| Carlstedt, G | 1 |
| Dahl, P | 1 |
| Niklasson, PM | 1 |
| Gullberg, K | 1 |
| Banck, G | 1 |
| Kahlmeter, G | 1 |
| Cherubin, CE | 1 |
| Kowalski, J | 1 |
| Minamitani, M | 1 |
| Hachimori, K | 1 |
| Kaneda, K | 1 |
| Phuapradit, P | 1 |
| Lachaux, A | 1 |
| Descos, B | 1 |
| Loras-Duclaux, I | 1 |
| Souillet, G | 1 |
| Floret, D | 1 |
| Brunet, J | 1 |
| Freney, J | 1 |
| Hermier, M | 1 |
| Aoki, T | 1 |
| Shimizu, N | 1 |
| Tomizawa, I | 1 |
| Takizawa, Y | 1 |
| Matsubara, Y | 1 |
| Seo, T | 1 |
| Sagara, H | 1 |
| Tagawa, K | 1 |
| Masuda, G | 1 |
| Negishi, M | 1 |
| Ode, B | 1 |
| Hansson, AM | 1 |
| Heseltine, PN | 1 |
| Causey, DM | 1 |
| Appleman, MD | 1 |
| Corrado, ML | 1 |
| Leedom, JM | 1 |
| Abom, PE | 1 |
8 trials available for norfloxacin and Infections, Salmonella
| Article | Year |
|---|---|
Norfloxacin and azithromycin for treatment of nontyphoidal salmonella carriers.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Typing Tech | 2003 |
Salmonella gastroenteritis: longterm follow-up of an outbreak after treatment with norfloxacin or co-trimoxazole.
Topics: Adult; Aged; Disease Outbreaks; Drug Resistance, Microbial; Feces; Female; Follow-Up Studies; Humans | 1994 |
Short-course norfloxacin and trimethoprim-sulfamethoxazole treatment of shigellosis and salmonellosis in Egypt.
Topics: Adult; Aged; Developing Countries; Diarrhea; Double-Blind Method; Drug Administration Schedule; Dyse | 1994 |
Norfloxacin and Salmonella excretion in acute gastroenteritis--a 6-month follow-up study.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Carrier State; Double-Blind Method; F | 1996 |
Comparison of the efficacy of ceftibuten and norfloxacin in the treatment of acute gastrointestinal infection in children.
Topics: Acute Disease; Anti-Infective Agents; Ceftibuten; Cephalosporins; Child; Child, Preschool; Diarrhea; | 1999 |
Empiric treatment of acute diarrheal disease with norfloxacin. A randomized, placebo-controlled study. Swedish Study Group.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Child; Diarrhea; Double-Blind Method; Fem | 1992 |
[Evaluation of norfloxacin in the pediatric field. Pediatric Study Group for Norfloxacin].
Topics: Administration, Oral; Bacterial Infections; Campylobacter Infections; Child; Child, Preschool; Drug | 1990 |
Norfloxacin treatment of salmonellosis does not shorten the carrier stage.
Topics: Adult; Carrier State; Disease Outbreaks; Feces; Female; Humans; Male; Norfloxacin; Prospective Studi | 1990 |
16 other studies available for norfloxacin and Infections, Salmonella
| Article | Year |
|---|---|
Quinolone Resistance Determinants of Clinical Salmonella Enteritidis in Thailand.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clone Cells; DNA Gyrase; Drug Resistance, Bacterial; Gene Expr | 2017 |
[Spontaneous infection of ascitic fluid due to Salmonella typhimurium in a cirrhotic patient undergoing selective intestinal decontamination with norfloxacin].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Ascitic Fluid; Blood; Cefotaxi | 2003 |
Salmonellosis and ulcerative colitis. A causal relationship or just a coincidence.
Topics: Abdomen, Acute; Adult; Biopsy, Needle; Colitis, Ulcerative; Colonoscopy; Drug Therapy, Combination; | 2004 |
In vitro susceptibility of multiple drug resistant Salmonella typhimurium to newer fluroquinolone derivatives.
Topics: Anti-Infective Agents; Ciprofloxacin; Diarrhea, Infantile; Drug Resistance, Multiple; Humans; In Vit | 1995 |
Isolation of Salmonella enterica serotype Worthington from a splenic abscess in a patient with chronic myeloid leukemia.
Topics: Abscess; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Multiple, Bacteria | 2002 |
Endotoxin release after antibiotic treatment and its potential pathogenetic role in coagulative disorders of patients with gram-negative sepsis.
Topics: Anti-Infective Agents; Blood Coagulation Disorders; Endotoxins; Humans; Norfloxacin; Ofloxacin; Salm | 1991 |
Antibiotic susceptibility pattern of Salmonella worthington isolated from neonates--a retrospective study.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Chloramphenicol; Ciprofloxacin; | 2002 |
Salmonella typhimurium-associated severe protracted diarrhea in infants and young children.
Topics: Amikacin; Combined Modality Therapy; Diarrhea, Infantile; Failure to Thrive; Female; Fluid Therapy; | 1990 |
Nontyphoid Salmonella carrier state treated with norfloxin.
Topics: Adult; Aged; Carrier State; Female; Humans; Middle Aged; Norfloxacin; Salmonella Infections | 1990 |
[Clinical study on norfloxacin in pediatrics].
Topics: Adolescent; Age Factors; Campylobacter Infections; Child; Child, Preschool; Drug Evaluation; Dysente | 1990 |
Failure of norfloxacin to eradicate intestinal colonization of non-typhoidal salmonella in infants.
Topics: Humans; Infant; Intestines; Male; Norfloxacin; Salmonella; Salmonella Infections | 1989 |
[Recurrent infections caused by Salmonella typhimurium].
Topics: Anti-Bacterial Agents; Child, Preschool; Female; Humans; Immunologic Deficiency Syndromes; Neutrophi | 1988 |
[Clinical study of AM-715 on acute infectious enteritis. The Japan Research Committee of AM-715, Research Group for Acute Infectious Enteritis].
Topics: Acute Disease; Administration, Oral; Campylobacter Infections; Drug Administration Schedule; Dysente | 1986 |
[A retrospective study: treatment of Salmonella infections with quinoline preparations].
Topics: Aged; Drug Therapy, Combination; Humans; Male; Norfloxacin; Retrospective Studies; Salmonella Infect | 1988 |
Norfloxacin in the eradication of enteric infections in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Humans; Intestinal Diseases; Male; Norfloxacin; Recurrenc | 1988 |
[3 Salmonella carriers successfully treated with a new antibiotic].
Topics: Adult; Carrier State; Female; Humans; Male; Norfloxacin; Salmonella Infections | 1987 |